Effect of treatment with the molecular adsorbents recirculating system on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 10, 2004, Pages 974-980

  Schmidt, Lars E ^a   Tofteng, F ^a   Strauss, G I ^a   Larsen, F S ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Albumin dialysis; Amino acids; Ammonia; Cerebral blood flow; Cerebral metabolism; Hepatic encephalopathy; Liver assist; Liver failure

Indexed keywords

ADSORBENT; ALANINE AMINOTRANSFERASE;

ALBUMIN DIALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; MALE; METABOLIC RATE; PRIORITY JOURNAL;

ADULT; ALBUMINS; AMINO ACIDS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD-BRAIN BARRIER; COMBINED MODALITY THERAPY; CRITICAL ILLNESS; FEMALE; HEMODIAFILTRATION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SORPTION DETOXIFICATION; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 6344270439     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410003227     Document Type: Article

References (25)

1. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976;6:387-94.
2. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977;72:483-7.
3. Knudsen GM, Schmidt J, Almdal T, Paulson OB, Vilstrup H. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy. Hepatology 1993;17:987-92.
4. Clemmesen JO, Kondrup J, Ott P. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 2000;118:1131-9.
5. Strauss GI, Knudsen GM, Kondrup J, Møller K, Larsen FS. Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology 2001;121:1109-19.
6. Zieve L, Olsen RL. Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? Gut 1977;18:688-91.
7. Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975;78:276-90.
8. Cooper AJ, Lai JC. Cerebral ammonia metabolism in normal and hyperammonemic rats. Neurochem Pathol 1987;6:67-95.
9. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979;161:303-10.
10. Norenberg MD, Baker L, Norenberg LO, Blicharska J, Bruce-Gregorios JH, Neary JT. Ammonia-induced astrocyte swelling in primary culture. Neurochem Res 1991;16:833-6.
11. Stange J, Mitzner S. A carrier-mediated transport of toxins in hybrid membrane. Safety barrier between a patient's blood and a bioartificial liver. Int J Artif Organs 1996;19:677-91.
12. Stange J, Mitzner S, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular Adsorbent Recycling System (MARS). Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
13. Loock J, Mitzner SR, Peters E, Schmidt R, Stange J. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS). Liver 2002;22 Suppl 2:35-39.
14. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949-58.
15. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976;80:77-91.
16. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000;6:277-86.
17. Møller K, Strauss GI, Qvist J, Fonsmark L, Knudsen GM, Larsen FS, et al. Cerebral blood flow and oxidative metabolism during human endotoxemia. J Cereb Blood Flow Metab 2002;22:1262-70.
18. Kety SS, Schmidt CF. The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Am J Physiol 1945;143:53-66.
19. Denis J, Opolon P, Nusinovici V, Granger A, Darnis F. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978;19:787-93.
20. Gazzard BG, Weston MJ, Murray-Lyon IM, Flax H, Record CO, Williams R, et al. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974;1:1301-7.
21. Bihari D, Hughes RD, Gimson AE, Langley PG, Ede RJ, Eder G, et al. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int J Artif Organs 1983;6:299-302.
22. Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol 2001;96:1217-23.
23. Subrahmanyam K, Prasad MS, Rangavalli G, Muralidhar K, Sadasivudu B. Functional relationship of ammonia to DNA, RNA and protein in brain. Neuroscience 1985;15:887-90.
24. Sobel RA, DeArmond SJ, Forno LS, Eng LF. Glial fibrillary acidic protein in hepatic encephalopathy. An immunohistochemical study. J Neuropathol Exp Neurol 1981;40:625-32.
25. Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 1978;187:343-50.